| Code | 3865D | ||||||||||
| MA number | 69/0065/20-S | ||||||||||
| Product Form: | pas ord 8x8,75 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oropharyngeal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 21.06.2020 |
| Validity: | 21.06.2025 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Martifen 8,75 mg_12/2023.pdf
|
| SPC: |
SPC_Martifen 8,75 mg_12/2023.pdf
|
| Safety feature | No |
| Data update: | 06.07.2020 |
